6-Methoxy-9-(β-D-3-deoxyribofuranosyl)-9H-purine is a purine nucleoside analog with broad antitumor activity, particularly targeting indolent lymphoid malignancies. Its anticancer mechanism involves inhibition of DNA synthesis and induction of apoptosis.